These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 216993)

  • 1. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
    North TW; Cohen SS
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chirality in 9-(2-hydroxy-3-nonyl)adenine upon deoxyribonucleic acid synthesis in herpes simplex virus-infected cells.
    North TW; O'Connor L; Abushanab E; Panzica RP
    Biochem Pharmacol; 1983 Dec; 32(23):3541-6. PubMed ID: 6316987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of herpes simplex virus replication by purine deoxyribonucleosides.
    North TW
    Cancer Res; 1984 Apr; 44(4):1415-9. PubMed ID: 6322976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
    J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
    J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
    Williams BB; Lerner AM
    J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
    Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
    Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W; Cohen SS
    Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.
    Lambe CU; Nelson DJ
    Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of erythro-9(2-hydroxy-3-nonyl) adenine (EHNA) on HIV-1 production in vitro.
    Sei Y; Inoue M; Tsuboi I; Yokoyama MM; Arora PK
    Biochem Biophys Res Commun; 1989 Oct; 164(1):345-50. PubMed ID: 2478129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
    Schwartz PM; Shipman C; Drach JC
    Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human T-cell rosette formation by the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Schmidtke JR; Sutherland DE; Najarian JS
    Clin Immunol Immunopathol; 1978 Jul; 10(3):258-61. PubMed ID: 307473
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.
    Bessodes M; Bastian G; Abushanab E; Panzica RP; Berman SF; Marcaccio EJ; Chen SF; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1982 Mar; 31(5):879-82. PubMed ID: 7082355
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
    Lum CT; Sutherland DE; Najarian JS
    Clin Immunol Immunopathol; 1979 Apr; 12(4):453-9. PubMed ID: 222523
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA.
    Lupidi G; Cristalli G; Marmocchi F; Riva F; Grifantini M
    J Enzyme Inhib; 1985; 1(1):67-75. PubMed ID: 3916912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase.
    Mendelson WB; Kuruvilla A; Watlington T; Goehl K; Paul SM; Skolnick P
    Psychopharmacology (Berl); 1983; 79(2-3):126-9. PubMed ID: 6405420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cells.
    Chen SF; Stoeckler JD; Choi HS; Burgess FW; Marcaccio EJ; Steen PA; Berman SF; Parks RE; Panzica RP; Abushanab E
    Biochem Pharmacol; 1982 Dec; 31(24):3955-60. PubMed ID: 7159473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
    Svendsen KR; Overgaard-Hansen K; Frederiksen S
    Cancer Chemother Pharmacol; 1988; 21(1):35-9. PubMed ID: 3257721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protonated form of 1-N6-etheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine is identified at the active site of adenosine deaminase.
    Caiolfa VR; Gill D; Parola AH
    FEBS Lett; 1990 Jan; 260(1):19-22. PubMed ID: 2153576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
    Goday A; Simmonds HA; Webster DR; Morris GS
    Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.